Cargando…
Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690050/ https://www.ncbi.nlm.nih.gov/pubmed/34950473 http://dx.doi.org/10.1093/ckj/sfab171 |
| _version_ | 1784618608537632768 |
|---|---|
| author | Lamy, Gaspard Vauloup Fellous, Christelle Mouna, Lina Dargelos, Mathilde Vilaine, Eve Couturier, Aymeric Chhom, Panha Essig, Marie Massy, Ziad A |
| author_facet | Lamy, Gaspard Vauloup Fellous, Christelle Mouna, Lina Dargelos, Mathilde Vilaine, Eve Couturier, Aymeric Chhom, Panha Essig, Marie Massy, Ziad A |
| author_sort | Lamy, Gaspard |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8690050 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86900502021-12-22 Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients Lamy, Gaspard Vauloup Fellous, Christelle Mouna, Lina Dargelos, Mathilde Vilaine, Eve Couturier, Aymeric Chhom, Panha Essig, Marie Massy, Ziad A Clin Kidney J Letter to the Editor Oxford University Press 2021-09-23 /pmc/articles/PMC8690050/ /pubmed/34950473 http://dx.doi.org/10.1093/ckj/sfab171 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of ERA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letter to the Editor Lamy, Gaspard Vauloup Fellous, Christelle Mouna, Lina Dargelos, Mathilde Vilaine, Eve Couturier, Aymeric Chhom, Panha Essig, Marie Massy, Ziad A Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients |
| title | Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients |
| title_full | Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients |
| title_fullStr | Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients |
| title_full_unstemmed | Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients |
| title_short | Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients |
| title_sort | heterogeneous neutralizing antibodies production after sars-cov-2 vaccination in haemodialysis patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690050/ https://www.ncbi.nlm.nih.gov/pubmed/34950473 http://dx.doi.org/10.1093/ckj/sfab171 |
| work_keys_str_mv | AT lamygaspard heterogeneousneutralizingantibodiesproductionaftersarscov2vaccinationinhaemodialysispatients AT vauloupfellouschristelle heterogeneousneutralizingantibodiesproductionaftersarscov2vaccinationinhaemodialysispatients AT mounalina heterogeneousneutralizingantibodiesproductionaftersarscov2vaccinationinhaemodialysispatients AT dargelosmathilde heterogeneousneutralizingantibodiesproductionaftersarscov2vaccinationinhaemodialysispatients AT vilaineeve heterogeneousneutralizingantibodiesproductionaftersarscov2vaccinationinhaemodialysispatients AT couturieraymeric heterogeneousneutralizingantibodiesproductionaftersarscov2vaccinationinhaemodialysispatients AT chhompanha heterogeneousneutralizingantibodiesproductionaftersarscov2vaccinationinhaemodialysispatients AT essigmarie heterogeneousneutralizingantibodiesproductionaftersarscov2vaccinationinhaemodialysispatients AT massyziada heterogeneousneutralizingantibodiesproductionaftersarscov2vaccinationinhaemodialysispatients |